Wobke E M van Dijk
Overview
Explore the profile of Wobke E M van Dijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Leeuwen F, Foppen W, de Jong P, van Dijk W, Blokzijl J, Fischer K, et al.
Res Pract Thromb Haemost
. 2024 Apr;
8(2):102372.
PMID: 38590365
Background: Ultrasound is increasingly used for musculoskeletal assessment in hemophilia care. Objectives: To evaluate the impact of point-of-care ultrasound added to clinical assessment for diagnosis and treatment of acute musculoskeletal...
2.
van Dijk W, Poolen G, Huisman A, Koene H, Fijnheer R, Thielen N, et al.
J Thromb Haemost
. 2023 Jan;
21(4):1020-1031.
PMID: 36696209
Background: Thrombopoietin receptor agonists are frequently used in treating immune thrombocytopenia (ITP) owing to high response rates and good tolerability. ITP is associated with an increased risk of thrombosis. Whether...
3.
van Dijk W, Nap-van der Vlist M, Knoop H, Schutgens R
TH Open
. 2022 Dec;
6(4):e387-e395.
PMID: 36452201
Fatigue in immune thrombocytopenia (ITP) is frequent and burdensome, but we lack the knowledge to help these patients. The aim of the study is to explore the role of disease...
4.
van Dijk W, Punt M, van Galen K, van Leeuwen J, Lely A, Schutgens R
Br J Haematol
. 2022 Jun;
198(4):753-764.
PMID: 35662003
Immune thrombocytopenia (ITP) may cause menstrual problems. This cross-sectional study assessed menstrual problems in premenopausal chronic ITP women by several questionnaires, including the pictorial bleeding assessment calendar (PBAC; score ≥100...
5.
van Dijk W, Penson A, Kuijlaars I, Suijker M, van Galen K, Knoop H, et al.
Br J Haematol
. 2022 Jan;
197(3):e41-e44.
PMID: 34993959
No abstract available.
6.
van Dijk W, Schutgens R
N Engl J Med
. 2021 Dec;
385(23):2201.
PMID: 34874643
No abstract available.
7.
van Dijk W, van Es R, Correa M, Schutgens R, van Galen K
TH Open
. 2021 Nov;
5(4):e489-e502.
PMID: 34805736
Dentoalveolar procedures in immune thrombocytopenia (ITP) pose a risk of bleeding due to thrombocytopenia and infection due to immunosuppressive treatments. We aimed to systematically review the safety and management of...
8.
van Dijk W, Schutgens R
Eur J Haematol
. 2021 Sep;
108(1):84-85.
PMID: 34591991
No abstract available.
9.
van Dijk W, Nijdam J, Haitjema S, de Groot M, Huisman A, Punt M, et al.
J Thromb Haemost
. 2021 Aug;
19(11):2873-2883.
PMID: 34339085
Background: Severe postpartum hemorrhage (SPPH) is the leading cause of maternal mortality and morbidity worldwide. Platelet anomalies frequently occur during pregnancy. However, their role in the etiology of SPPH is...
10.
van Dijk W, Brandwijk O, Heitink-Polle K, Schutgens R, van Galen K, Urbanus R
Blood Rev
. 2020 Nov;
47:100774.
PMID: 33213987
Thrombopoietin receptor agonist (TPO-RA) treatment increases the thrombosis rate in immune thrombocytopenia (ITP). We hypothesize that TPO-RAs influence platelet function, global and secondary hemostasis and/or fibrinolysis. A systematic review was...